Search Results - "Leverenz, Jim"

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease by Kang, Ju-Hee, Irwin, David J, Chen-Plotkin, Alice S, Siderowf, Andrew, Caspell, Chelsea, Coffey, Christopher S, Waligórska, Teresa, Taylor, Peggy, Pan, Sarah, Frasier, Mark, Marek, Kenneth, Kieburtz, Karl, Jennings, Danna, Simuni, Tanya, Tanner, Caroline M, Singleton, Andrew, Toga, Arthur W, Chowdhury, Sohini, Mollenhauer, Brit, Trojanowski, John Q, Shaw, Leslie M

“…We observed a significant correlation between cerebrospinal fluid (CSF) levels of tau proteins and α-synuclein, but not β-amyloid 1-42 (Aβ1-42), and lower…”
Get more information

Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease by Mollenhauer, Brit, Caspell‐Garcia, Chelsea J., Coffey, Christopher S., Taylor, Peggy, Singleton, Andy, Shaw, Leslie M., Trojanowski, John Q., Frasier, Mark, Simuni, Tanya, Iranzo, Alex, Oertel, Wolfgang, Siderowf, Andrew, Weintraub, Daniel, Seibyl, John, Toga, Arthur W., Tanner, Caroline M., Kieburtz, Karl, Chahine, Lana M., Marek, Kenneth, Galasko, Douglas

“…Background Aggregation of α‐synuclein is central to the pathophysiology of PD. Biomarkers related to α‐synuclein may be informative for PD…”
Get full text

Early β-amyloid deposition in hippocampal neurons in β-amyloid precursor protein 695 (APP695) transgenic mice by Shie, Feng-Shiun, Jin, Lee-Way, Leverenz, Jim, LeBoeuf, Renee

Get full text